Evidence map›Paper›PMID 20631691›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2010

Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanism.

Pouya Tahsili-Fahadan, Gregory V Carr, Glenda C Harris, Gary Aston-Jones

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Modafinil, an atypical CNS stimulant?Advances in pharmacology (San Diego, Calif.) · 2024
    Article
  2. Article
  3. Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  9. Article
  10. Review
  11. R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  12. Article
  13. Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2014
    Review
  14. Article
  15. Review
  16. Article
  17. Glutamate mechanisms underlying opiate memories.Cold Spring Harbor perspectives in medicine · 2012
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pouya Tahsili-FahadanDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Gregory V Carr
Glenda C Harris
Gary Aston-Jones
Medical University of South Carolina · USUniversity of Pennsylvania · US

Funding

Selective Restoration of KCNQ Channel Inhibition in the PFC to Inhibit Cue-InducP50DA015369 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2003 to 2017
$18.6M
Role of Extended Amygdala in Opiate and Cocaine AbuseR37DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 2003 to 2012
$4.2M
Alterations in Reward Processing During Drug AbstinenceR01DA017289 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 2005 to 2009
$1.4M
NIDA NIH HHS P50 DA015369NIDA NIH HHS R01 DA017289NIDA NIH HHS R37 DA006214NIDA NIH HHS R37 DA06214
6 · The paper itself

Abstract

Opiate addiction is characterized by high rates of relapse even after long periods of abstinence, requiring new relapse-prevention treatments that do not have abuse potential. Recently, clinical studies suggested that the wake-promoting drug modafinil might decrease relapse in cocaine addicts. In addition, group II metabotropic glutamate receptors (mGlu2/3R) have been suggested as a new therapeutic target for drug addiction. Here, we investigated the ability of modafinil to prevent the acute morphine to promote reinstatement of extinguished preference for morphine, and the involvement of mGlu2/3Rs in this effect. Conditioned place preference (CPP) for morphine was induced in Sprague-Dawley rats, followed by extinction training. Preference for the morphine-paired side was reinstated following extinction by a morphine-priming injection. The results of our study showed that modafinil (300 mg/kg, i.p., but not 100 mg/kg) 30 min before the morphine-priming injection blocked reinstatement of extinguished CPP. The anti-reinstatement effect of modafinil was completely prevented by pretreatment with the selective mGlu2/3 antagonist LY341495. Additional experiments indicated that modafinil alone did not produce a preference, and that modafinil did not alter the expression of morphine CPP or the cueing properties of morphine either 1 or 14 days after morphine CPP conditioning. These data reveal a novel mechanism for modafinil actions, a role for mGlu2/3 receptors in reinstatement of opiate-seeking, and a new therapeutic option to treat relapse in opiate addiction.

Indexed as

AnimalsBehavior, AddictiveBenzhydryl CompoundsConditioning, PsychologicalExtinction, PsychologicalGlutamic AcidMaleModafinilMorphineRandom AllocationRatsRats, Sprague-DawleyReceptors, Metabotropic GlutamateBenzhydryl CompoundsGlutamic Acidmetabotropic glutamate receptor 2metabotropic glutamate receptor 3ModafinilMorphineReceptors, Metabotropic Glutamate

Identifiers

PMID20631691
PMCPMC2939923
OpenAlexW2062776797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.